Draft ICH guideline S7B: Guideline on safety pharmacology studies for assessing the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals.
2003 ◽
Vol 121
(6)
◽
pp. 377-383
◽
2009 ◽
Vol 60
(2)
◽
pp. 107-116
◽
Keyword(s):
2006 ◽
Vol 37
(4)
◽
pp. 201-206
◽
2006 ◽
Vol 37
(4)
◽
pp. 207-214
◽
2005 ◽
Vol 99
(5)
◽
pp. 501-511
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):